HR Execs on the Move

Intellivisit

www.intellivisit.com

 
Intellivisit Solutions is a healthcare technology and modern urgent care consulting company. Our technology, Intellivisit, is a real-time artificial intelligence decision support tool specifically designed by our experts to enhance urgent care teams. Our consulting, UCP Merchant Medicine, is a full-service, turn-key consulting firm focused on improving strategic, financial, and operational outcomes with our modern urgent care model.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

CBD Farmhouse

CBD Farmhouse™ is committed to set standards of excellence in organic quality and affordable products from our USDA hemp farm to finished products. We take pride to inspire, educate, and empower the CBD community. This isn’t just a mission- it’s our pa...

Brotoloc Inc

Brotoloc Inc is a Eau Claire, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Providence and LogistiCare

The Providence Service Corporation, through its fully-owned subsidiary LogistiCare Solutions, LLC, is the nation`s largest manager of non-emergency medical transportation programs for state governments and managed care organizations. Its range of services includes call center management, network credentialing, vendor payment management and non-emergency medical transport management. The Company also holds a minority interest in Matrix Medical Network which provides a broad array of assessment and care management services to individuals that improve health outcomes and health plan financial performance.

Analytics For Life

Analytics 4 Life® is pioneering digital health using artificial intelligence to develop a completely new form of medical imaging. With an initial focus on coronary artery disease and pulmonary hypertension, Analytics 4 Life is advancing a novel, radiation-free, and exercise-free cardiac imaging technology aimed at improving existing care pathways. Analytics 4 Life is based in Toronto with U.S. headquarters in Research Triangle Park, NC.

Avaxia Biologics

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.